Data presented at ASPN demonstrate the AI model's ability to identify patients who may benefit from support, often before they recognize a problem themselves¹

在 ASPN 会议上展示的数据表明，该人工智能模型能够识别可能从支持中受益的患者，且往往在患者自身意识到问题之前¹

MIAMI

迈阿密

,

，

July 20, 2026

2026年7月20日

/PRNewswire/ -- BIOTRONIK Neuro today announced the launch of Embrace One

/PRNewswire/ -- BIOTRONIK Neuro 今日宣布推出 Embrace One

®

®

Proactive Intelligence, a proprietary AI capability that advances proactive care for patients implanted with the Prospera

主动智能，一项专有的AI能力，旨在提升植入Prospera设备的患者的主动护理水平

®

®

Spinal Cord Stimulation (SCS) System. BIOTRONIK Neuro collects more than 200 data points per patient daily through automatic, objective remote monitoring, and the new AI capability analyzes this data to identify early signals that may indicate a patient could benefit from additional support or therapy optimization..

脊髓刺激（SCS）系统。BIOTRONIK Neuro 通过自动、客观的远程监测，每天为每位患者收集超过 200 个数据点，而新的人工智能功能则对这些数据进行分析，以识别可能表明患者可从额外支持或治疗优化中受益的早期信号。

Continue Reading

继续阅读

Prospera Spinal Cord Stimulation System

Prospera 脊髓刺激系统

The AI model does not make clinical decisions or adjust therapy. Instead, it provides additional insight to BIOTRONIK Neuro's Embrace One Care Team—a dedicated group of clinical specialists who actively monitor patients and provide timely, personalized care between office visits—to help prioritize patient outreach and follow-up support.

该人工智能模型不做出临床决策或调整治疗方案。相反，它为 BIOTRONIK Neuro 的 Embrace One 护理团队提供额外的洞察支持。该团队由一群专门的临床专家组成，负责主动监测患者，并在门诊就诊间隙提供及时、个性化的护理，以帮助确定患者联系和后续支持的优先顺序。

Because Embrace One Proactive Intelligence uses data already collected through the Prospera system, it requires no additional effort from patients or healthcare providers..

由于Embrace One主动智能系统使用通过Prospera系统已经收集的数据，因此患者和医疗保健提供者无需付出额外努力。

New real-world data presented at the American Society of Pain and Neuroscience (ASPN) Annual Meeting demonstrated the AI model's ability to identify patients who may benefit from proactive outreach. In a prospective pilot study, the model identified 188 behavioral-pattern instances across 175 patients for review by the Embrace One Care Team.

在美国疼痛与神经科学学会（ASPN）年会上展示的最新真实世界数据表明，该人工智能模型能够识别可能从主动外展服务中受益的患者。在一项前瞻性试点研究中，该模型在175名患者中识别出188个行为模式实例，供Embrace One护理团队审查。

Patients responded to proactive outreach in 80.9% of cases. Overall, nearly 4 out of 5 cases resulted in targeted support from the Embrace One Care Team, including remote reprogramming, therapy optimization, and additional patient education.¹.

在80.9%的病例中，患者对主动外展服务作出了响应。总体而言，近五分之四的病例获得了来自Embrace One护理团队的针对性支持，包括远程重新编程、治疗优化以及额外的患者教育。¹

'This level of support gives me great peace of mind,' said David Dickerson, MD, Endeavor Health, Chicago, IL. 'One of the challenges in managing SCS therapy is that patients don't always recognize how subtle changes in their behavior may impact pain relief. Proactive Intelligence strengthens the Embrace One Care Team's ability to identify patients who may benefit from outreach, creating more opportunities to address issues proactively and connect patients with the support they need.'.

“这种程度的支持让我倍感安心，”来自伊利诺伊州芝加哥市 Endeavor Health 的 David Dickerson 医学博士表示。“管理脊髓电刺激（SCS）疗法的挑战之一在于，患者并不总能意识到其行为的细微变化可能会影响疼痛缓解效果。Proactive Intelligence 增强了 Embrace One 护理团队识别可能从主动干预中受益的患者的能力，从而创造更多机会来主动解决问题，并将患者与所需的支持资源相连接。”

Historically, post-implant SCS management has relied on patients recognizing therapy issues and initiating follow-up care themselves. As the first and only SCS manufacturer to offer automatic, objective daily remote monitoring and remote programming, BIOTRONIK Neuro established a new standard for proactive SCS management that combines continuous passive monitoring with personalized support from the Embrace One Care Team..

历史上，脊髓刺激（SCS）植入后的管理一直依赖于患者自行识别治疗问题并主动发起随访护理。作为首家且唯一一家提供自动、客观的每日远程监测和远程程控的SCS制造商，BIOTRONIK Neuro确立了主动性SCS管理的新标准，将持续的被动监测与Embrace One护理团队的个性化支持相结合。

Real-time visibility into therapy performance and device data enables BIOTRONIK Neuro's team of clinical experts to identify potential issues and help address them before pain relief is compromised. Embrace One Proactive Intelligence enhances these capabilities through AI modeling that helps prioritize patients for proactive outreach by the Embrace One Care Team..

对治疗表现和设备数据的实时可视性，使 BIOTRONIK Neuro 的临床专家团队能够识别潜在问题，并在疼痛缓解效果受到影响之前加以解决。Embrace One Proactive Intelligence 通过人工智能建模进一步增强这些能力，帮助 Embrace One 护理团队优先确定需要主动联系的患者。

'BIOTRONIK Neuro is uniquely positioned to bring AI-assisted support to spinal cord stimulation because of the rich, continuously expanding real-world dataset generated through our remote monitoring capabilities,' said Holger Krumel, Chief Executive Officer, BIOTRONIK Group. 'This innovation reflects our longstanding commitment to developing technologies that support patients beyond the clinic.

“凭借我们通过远程监测功能生成的丰富且不断扩展的真实世界数据集，BIOTRONIK Neuro 在提供人工智能辅助的脊髓刺激支持方面具有独特优势。”BIOTRONIK集团首席执行官Holger Krumel表示。“这一创新体现了我们长期以来致力于开发超越诊所范畴、为患者提供支持的技术的承诺。”

By combining remote monitoring, personalized support, and AI-driven intelligence, we are advancing proactive care and helping SCS patients achieve stable, long-term relief.'.

通过结合远程监测、个性化支持和人工智能驱动的智能技术，我们正在推进主动护理，帮助脊髓刺激（SCS）患者获得稳定且长期的缓解。

Remote Management of Spinal Cord Stimulation Devices for Chronic Pain

慢性疼痛脊髓刺激设备的远程管理

Spinal cord stimulation is a proven, widely used treatment for chronic pain, delivering electrical impulses to the spinal cord to modulate nerve activity and reduce pain signals. Traditional SCS systems often require frequent in-office visits for reprogramming, resulting in therapy delays, patient travel burdens, and higher costs..

脊髓刺激是一种经过验证且广泛应用的慢性疼痛治疗方法，通过向脊髓输送电脉冲来调节神经活动并减轻疼痛信号。传统的脊髓刺激系统通常需要频繁前往诊所进行重新编程，导致治疗延迟、增加患者的出行负担以及提高成本。

2

2

Emerging expert recommendations

新兴专家建议

highlight the potential benefits of SCS systems with remote monitoring capabilities, which enable timely adjustments, minimize in-person visits, and may improve long-term outcomes by enhancing therapy management and patient convenience.

强调具备远程监测功能的脊髓刺激（SCS）系统的潜在优势，这些系统能够实现及时调整、减少面对面就诊次数，并通过优化治疗管理和提升患者便利性来改善长期预后。

About the Prospera Spinal Cord Stimulation System

关于 Prospera 脊髓刺激系统

The Prospera Spinal Cord Stimulation system – with remote monitoring and proactive care via the Embrace One Care Team – delivers RESONANCE™, the only multiphase stimulation paradigm available. BIOTRONIK Neuro is the first and only manufacturer to offer daily remote monitoring, automatic objective data transmission and remote programming in the SCS space.

Prospera 脊髓刺激系统——通过 Embrace One 护理团队提供远程监测和主动护理——提供 RESONANCE™，这是目前唯一可用的多相位刺激模式。BIOTRONIK Neuro 是脊髓刺激（SCS）领域中首家也是唯一一家提供每日远程监测、自动客观数据传输和远程编程的制造商。

This system allows therapy adjustments in real time, reducing the need for frequent in-person visits. By facilitating faster issue identification and management, Prospera enables therapy optimization, which may improve long-term outcomes for patients with chronic intractable pain..

该系统支持实时调整治疗方案，从而减少频繁面对面就诊的需求。通过促进更快速的问题识别与管理，Prospera 能够实现治疗优化，进而可能改善慢性难治性疼痛患者的长期预后。

2,3

2,3

The Prospera SCS system is FDA-approved and only available in the U.S.

Prospera SCS 系统已获得美国食品药品监督管理局（FDA）批准，仅在美国提供。

See important safety information

查看重要安全信息

.

。

About BIOTRONIK Neuro

关于百多力神经

BIOTRONIK Neuro

百多力神经

is a division of BIOTRONIK, a leading medical device company that has been improving the lives of patients with heart and blood vessel diseases for decades. Leveraging BIOTRONIK's advanced cardiovascular technologies, BIOTRONIK Neuro has created a new approach to spinal cord stimulation (SCS) therapy management: one that's not just implanted, but truly connected to the needs of patients and providers.

是百多力（BIOTRONIK）旗下的一个部门。百多力是一家领先的医疗器械公司，数十年来一直致力于改善心脏和血管疾病患者的生活。依托百多力先进的心血管技术，百多力神经（BIOTRONIK Neuro）开创了一种全新的脊髓刺激（SCS）疗法管理模式：不仅实现植入，更真正契合患者与医疗提供者的需求。

Our goal is to redefine relief for patients experiencing chronic pain and to optimize the SCS experience daily, and over the lifetime of patient therapy. BIOTRONIK Neuro is based in Lake Oswego, Oregon..

我们的目标是重新定义慢性疼痛患者的缓解方案，并在患者治疗的整个生命周期中，持续优化脊髓刺激（SCS）的日常体验。BIOTRONIK Neuro 总部位于俄勒冈州莱克奥斯韦戈。

About BIOTRONIK

关于百多力

For over 60 years,

六十余年来，

BIOTRONIK

百多力

has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology.

始终站在医疗技术的前沿，开创突破性的创新成果，正在改变数百万受心脏病和慢性疼痛困扰的患者的生活。我们以将技术与人体无缝融合的深刻使命为根基，通过在心脏节律管理、监测和神经调控领域的先进主动植入设备，开发值得信赖且能够改变生命的治疗方案，同时在电生理学领域提供尖端解决方案。

From creating Germany's first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology..

从1963年研制出德国首台心脏起搏器，到如今在数字技术和传导系统起搏领域开拓新局，BIOTRONIK 不断提升质量、性能与创新的标杆。公司总部位于柏林，业务遍及美洲、欧洲中东及非洲（EMEA）和亚洲的100多个国家，致力于提供大胆且面向未来的解决方案，塑造下一代医疗技术。

For inquiries, contact:

如有咨询，请联系：

Corporate Communications

企业传播

[email protected]

[email protected]

+49 (0) 30 68905-1414

+49 (0) 30 68905-1414

Beth Richman

贝丝·里奇曼

(312) 806-8999

(312) 806-8999

[email protected]

[email protected]

References:

参考文献：

1.

1.

Dickerson

迪克森

, D.,

，D.，

et

和

al. A Real-World Pilot Integration of Human-In-Loop Artificial Intelligence in Proactive Patient Care. Oral presentation at the American Society of Pain and Neuroscience (

等人。《人工智能人机协同在主动患者护理中的真实世界试点整合》。在美国疼痛与神经科学学会上的口头报告（

ASPN

天冬酰胺合成酶

) Annual Meeting; July 16-19, 2026; Miami, FL.

) 年度会议；2026年7月16日至19日；佛罗里达州迈阿密。

2. Russo M, Yu J, Amirdelfan K, et al. Proactive Automatic Daily Remote Monitoring and Remote Programming Enable Rapid Optimization of SCS: 24-Month Results From a Prospective Multicenter Study. The American Society of Pain & Neuroscience July 17-20, 2025; Miami Beach, FL.

2. Russo M, Yu J, Amirdelfan K, 等. 前瞻性自动每日远程监测与远程编程实现脊髓电刺激（SCS）的快速优化：一项前瞻性多中心研究的24个月结果. 美国疼痛与神经科学学会会议，2025年7月17-20日；佛罗里达州迈阿密海滩.

3. Pope J, Kapural L, Gilligan C, et al. Long-term Optimization of Spinal Cord Stimulation Through Proactive Remote Monitoring: 12-Month Results from a Real-World Cohort. The American Society of Pain & Neuroscience July 17-20, 2025; Miami Beach, FL.

3. Pope J, Kapural L, Gilligan C, 等. 通过主动远程监测优化脊髓刺激的长期效果：来自真实世界队列的12个月结果。美国疼痛与神经科学学会，2025年7月17-20日；佛罗里达州迈阿密海滩。

SOURCE BIOTRONIK Neuro

来源：BIOTRONIK Neuro

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量与

Request a Demo

申请演示